Kobi Inbar

Dr. Kobi Inbar Has over 25 years of extensive entrepreneurial, managerial, R&D and business experience, working with both startups and investors in the life sciences and bio-medical industry. Dr. Inbar served as the CEO of TK Signal and was the VP Operations for Peptor. Prior to that, he served as the VP R&D at ProCognia (formerly GlycoData) and Head of the Drug Discovery Unit at Collgard Biopharmaceutical. Currently, Dr. Inbar serves as a V.P. R&D at Stockton Group, an Israeli innovative Agribio company that operates globally.

In his rich and multifaceted academic career, Dr. Inbar was the Academic Director of the Bio-Medical MBA Program at the Business School, The College of Management Academic Studies, Rishon LeZion, Israel. Currently, Dr. Inbar holds a double-position as a Senior Lecturer at the Det. of Economics and Business Management, the Faculty of Social Sciences and Humanities, Ariel University and at the Department of Industrial Engineering and Management, Azrieli College of Engineering, Jerusalem, where he has been recently appointed as the Head of MA Program of Technological Entrepreneurship.

Dr. Inbar is an Associate Lecturer in the BioMedical MBA Program, The Jerusalem School of Business, The Hebrew University of Jerusalem; School of Business Administration and The International School at Haifa University.

Dr. Inbar is the Head of eHealth Ventures Physician-Entrepreneurs Acceleration Program. He is an active member of The Forum for Education of Engineers In the 21st Century – The Samuel Neaman Institute for National Policy Research, The Technion, Israel. He is a member of the forum of the entrepreneurship and innovation centers in institutions of higher education, managed by the Council for Higher Education in Israel.

Dr. Inbar published many scientific and academic papers in top-tier journals and he is a highly sought-after lecturer in his fields of expertise.

Dr. Inbar holds a Ph.D. in Biochemistry and Microbiology from the Hebrew University of Jerusalem, as well as an MBA degree from the EMBA Program of the Arison School of Business, the Interdisciplinary Center in Herzliya.